Rajeshwar Prosad Mookerjee

Title: Innovations by Rajeshwar Prosad Mookerjee

Introduction

Rajeshwar Prosad Mookerjee is a notable inventor based in London, GB. He has made significant contributions to the field of medical research, particularly in the treatment of liver diseases. With a total of 6 patents, Mookerjee's work focuses on innovative methods to address critical health issues.

Latest Patents

Mookerjee's latest patents include groundbreaking methods for treating or preventing fibrosis in non-alcoholic fatty liver disease (NAFLD). His invention is based on the unexpected finding that ADRA2a antagonists can decrease fibrosis in NAFLD. By antagonizing ADRA2a, many of the unwanted consequences or symptoms of NAFLD, such as impaired cognitive activity and fibrosis progression, may be reduced. This invention identifies and provides ADRA2a antagonists that can be utilized in the treatment of fibrosis in NAFLD.

Another significant patent involves the treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies. This patent discloses methods for preventing, treating, and delaying the onset or progression of diseases related to hepatic stellate cells (HSCs), including NAFLD, fibrosis, and liver cancer, through the use of ammonia-lowering therapies.

Career Highlights

Mookerjee is currently associated with UCL Business Plc, where he continues to innovate and contribute to medical research. His work has garnered attention for its potential impact on treating liver diseases, which affect millions worldwide.

Collaborations

Mookerjee has collaborated with esteemed colleagues such as Rajiv Jalan and Krista Rombouts, further enhancing the scope and impact of his research.

Conclusion

Rajeshwar Prosad Mookerjee's contributions to medical innovation, particularly in the treatment of liver diseases, highlight his role as a leading inventor in the field. His patents reflect a commitment to improving health outcomes through scientific research and innovation.